{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:36:08Z","timestamp":1783154168568,"version":"3.54.6"},"reference-count":21,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/25\/N\/NZ4\/00250"],"award-info":[{"award-number":["2017\/25\/N\/NZ4\/00250"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmg.2021.104368","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T12:05:50Z","timestamp":1634645150000},"page":"104368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father"],"prefix":"10.1016","volume":"64","author":[{"given":"Marya","family":"Dushar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u0119drzej","family":"Nowaczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Pyr\u017cak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayane","family":"Akopyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"\u015amigiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Rydzanicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"P\u0142oski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Szcza\u0142uba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ejmg.2021.104368_bib1","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/sj.onc.1201750","article-title":"Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin","volume":"16","author":"Altomare","year":"1998","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ejmg.2021.104368_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jc.2013-3228","article-title":"Activating AKT2 mutation: hypoinsulinemic hypoketotic hypoglycemia","volume":"99","author":"Arya","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ejmg.2021.104368_bib4","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1002\/ajmg.a.36101","article-title":"The AKT genes and their roles in various disorders","volume":"161A","author":"Cohen","year":"2013","journal-title":"Am. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104368_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jpeds.2015.04.069","article-title":"MORFAN syndrome: an infantile hypoinsulinemic hypoketotic hypoglycemia due to an AKT2 mutation","volume":"167","author":"Garg","year":"2015","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104368_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI16885","article-title":"Severe diabetes, age dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2\/PKB beta","volume":"112","author":"Garofalo","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"5675","key":"10.1016\/j.ejmg.2021.104368_bib7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A family with severe insulin resistance and diabetes due to a mutation in AKT2","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ejmg.2021.104368_bib8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"Akt signalling in health and disease","volume":"23","author":"Hers","year":"2011","journal-title":"Cell. Signal."},{"issue":"6055","key":"10.1016\/j.ejmg.2021.104368_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1126\/science.1210878","article-title":"An activating mutation of AKT2 and human hypoglycemia","volume":"334","author":"Hussain","year":"2011","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejmg.2021.104368_bib10","first-page":"222","article-title":"Hypoketotic hypofattyacidaemic hypoinsulinaemic hypoglycaemia in a child with hemihypertrophy? A new syndrome","volume":"61","author":"Hussain","year":"2004","journal-title":"Horm. Res."},{"issue":"2\u20133","key":"10.1016\/j.ejmg.2021.104368_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ando.2007.02.007","article-title":"Inhibition paradoxale de la r\u00e9ponse somatotrope et corticotrope \u00e0 l'hypoglyc\u00e9mie par hyperinsulinisme endog\u00e8ne: \u00e0 propos d'une observation [Paradoxal growth hormone and cortisol response to hypoglycemia caused by endogenous hyperinsulinemia: a case report]","volume":"68","author":"Kaffel","year":"2007","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.ejmg.2021.104368_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s13340-020-00455-5","article-title":"Insulin resistance and exaggerated insulin sensitivity triggered by single-gene mutations in the insulin signaling pathway","volume":"12","author":"Kushi","year":"2021","journal-title":"Diabetol Int"},{"issue":"2","key":"10.1016\/j.ejmg.2021.104368_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1530\/EJE-17-0132","article-title":"Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase","volume":"177","author":"Leiter","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.ejmg.2021.104368_bib14","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1210\/jc.2017-00768","article-title":"Constitutive activation of AKT2 in humans leads to hypoglycemia without fatty liver or metabolic dyslipidemia","volume":"102","author":"Minic","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104368_bib15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","article-title":"Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum","volume":"21","author":"Parker","year":"2019","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104368_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41431-018-0254-8","article-title":"Novel calcineurin A (PPP3CA) variant associated with epilepsy, constitutive enzyme activation and downregulation of protein expression","volume":"27","author":"Rydzanicz","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2021.104368_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajmg.1320450424","article-title":"MORFAN: a new syndrome characterized by mental retardation, pre- and postnatal overgrowth, remarkable face and acanthosis nigricans in 5-year-old boy","volume":"45","author":"Seemanova","year":"1993","journal-title":"Am. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104368_bib18","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104368_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4274\/jcrpe.galenos.2020.2019.0084","article-title":"The effectiveness of sirolimus treatment in two rare disorders with nonketotic hypoinsulinemic hypoglycemia: the role of mTOR pathway","volume":"12","author":"Siklar","year":"2020","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"12","key":"10.1016\/j.ejmg.2021.104368_bib20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ejmg.2018.06.002","article-title":"Melbourne Genomics Health Alliance, Mirzaa G, Leventer R. Polymicrogyria in association with hypoglycemia points to mutation in the mTOR pathway","volume":"61","author":"Stutterd","year":"2018","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2021.104368_bib21","doi-asserted-by":"crossref","first-page":"45470","DOI":"10.18632\/oncotarget.17566","article-title":"The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K\/AKT\/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS)","volume":"8","author":"Suzuki","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmg.2021.104368_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221002342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221002342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:51:31Z","timestamp":1761709891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721221002342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1769721221002342"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104368","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104368"}}